# Vincent Woo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vincent-woo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,942 |
| Field | Diabetes Treatment and Management |
| h-index | 51 |
| i10-index | 91 |
| Last Known Institution | University of Manitoba |
| OpenAlex ID | https://openalex.org/A5032297044 |
| ORCID iD | https://orcid.org/0000-0003-1745-6381 |
| Works | 191 |

## Researcher papers

Showing 12 of 15.

- [Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension](https://scholariq.org/papers/the-2015-canadian-hypertension-education-program-recommendations-for-blood/)
- [Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children](https://scholariq.org/papers/hypertension-canada-s-2020-comprehensive-guidelines-for-the-prevention-diagnosis/)
- [Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children](https://scholariq.org/papers/hypertension-canada-s-2018-guidelines-for-diagnosis-risk-assessment-prevention/)
- [Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension](https://scholariq.org/papers/hypertension-canada-s-2016-canadian-hypertension-education-program-guidelines/)
- [The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy](https://scholariq.org/papers/the-2010-canadian-hypertension-education-program-recommendations-for-the/)
- [Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial](https://scholariq.org/papers/semaglutide-once-weekly-as-add-on-to-sglt-2-inhibitor-therapy-in-type-2-diabetes/)
- [Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults](https://scholariq.org/papers/hypertension-canada-s-2017-guidelines-for-diagnosis-risk-assessment-prevention/)
- [Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years](https://scholariq.org/papers/dapagliflozin-in-patients-with-type-2-diabetes-receiving-high-doses-of-insulin/)
- [Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled/)
- [The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension](https://scholariq.org/papers/the-2014-canadian-hypertension-education-program-recommendations-for-blood/)
- [The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy](https://scholariq.org/papers/the-2012-canadian-hypertension-education-program-recommendations-for-the/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

## Researcher university

- [University of Manitoba](https://scholariq.org/institutions/university-of-manitoba/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.